IDA chief executive Martin Shanahan is “cautiously optimistic” going into 2015. Photograph: Alan Betson/The Irish Times.

IDA Ireland, the State agency responsible for attracting inward investment, said it will publish a new five-year strategy in coming weeks that will pa(...)

Seagate’s spending put it in 126th place out of the top 2,500 companies in the world in the annual survey by the European Commission. Photograph: Paul Faith/PA Wire

A survey has found that Seagate Technology, an American data storage company, is the single biggest investor in research and development (R&D) in(...)

President Barack Obama and owner Mark Cuban participating in an event  at the White House. Photograph: Mark Wilson/Getty Images

A billionaire media tycoon with close links to US president Barack Obama has urged investors to sell the shares of companies that shift their headqua(...)

Johnny Ronan has found tenants for most of the vacant space in Connaught House, his upmarket office block on Burlington Road in Dublin 4.

Weeks after announcing that he is gearing up to re-enter the office construction market, Johnny Ronan has found tenants for most of the vacant space (...)

Out tomorrow: Euro zone retail sales (Mar). Photograph: Simon Dawson/Bloomberg

TODAYResults: Audi; Kennedy-Wilson; Manchester United; Pfizer. Indicators: Euro zone Sentix investor confidence (May) and producer prices (March); US (...)

Burlington House stands on a site of 0.68 of a hectare (1.68 acres) in Dublin 4

One of the best-located office redevelopment opportunities in Dublin city comes on the market today with the planned sale of a(...)

Séamus Mulligan  co-founded Dublin-based Adapt with fellow serial pharmaceutical entrepreneurs David Brabazon and Eunan Maguire

Entrepreneur Séamus Mulligan has cashed in shares worth $86 million (€62 million) in Jazz Pharmaceuticals which will entirely be used to fund a new(...)

TO DAY (...)

An Taoiseach Enda Kenny and Bruce Cozadd, chairman and chief executive of Jazz Pharmaceuticals plc, in  Monksland, Athlone, Co Roscommon, on Monday.

Jazz Pharmaceuticals is investing €50 million on a new manufacturing plant outside Athlone, Co Roscommon, that will create 50 high-skilled full-time j(...)

Jazz Pharmaceuticals, the Dublin-based maker of the narcolepsy treatment Xyrem, is buying Italian rare disease drug developer Gentium in a $1 billion (...)